- UroToday Home
- Urologic Oncology
The Latest Bladder Cancer Research
Recent Abstracts
-
Phase I first-in-human dose-escalation trial of a bladder cancer-specific nanoparticle in non-muscle-invasive bladder cancer.Bladder CancerJuly 9, 2026
-
Beyond the bladder: case series of Mycobacterium bovis bacillus Calmette-Guérin infections following intravesical instillation.Bladder CancerJuly 9, 2026
-
The impact of cachexia and sarcopenia in bladder cancer.Bladder CancerJuly 9, 2026
-
Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer.Bladder CancerJuly 8, 2026
-
The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study.Bladder CancerJuly 8, 2026
-
Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner.Bladder CancerJuly 7, 2026
-
Outcomes of maintenance BCG versus gemcitabine/docetaxel following BCG induction in NMIBC.Bladder CancerJuly 7, 2026
-
Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary Disease.Bladder CancerJuly 7, 2026
-
Time to Treatment Initiation and Survival in Patients With Muscle-Invasive Bladder Cancer (MIBC).Bladder CancerJuly 6, 2026
-
Predictors of residual tumour and recurrence in high-grade NMIBC: insights from a multicenter re-TURBT cohort.Bladder CancerJuly 6, 2026
Beyond the Abstracts
-
Diagnosis, Evaluation, and Management of Patients with Non-Muscle Invasive Bladder Cancer - Beyond the AbstractBladder CancerJuly 9, 2026
-
Outcomes of Consolidative Surgery Following Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A Real-World Experience - Beyond the AbstractBladder CancerJuly 8, 2026
-
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Long-Term Outcomes from the JAVELIN Bladder 100 Trial in Patients with High Body Mass Index or Diabetes Mellitus - Beyond the AbstractBladder CancerJuly 2, 2026
-
International Survey of Thromboprophylaxis Practices During Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer - Beyond the AbstractBladder CancerJuly 1, 2026
-
Targeting HER2 in Urothelial Carcinoma: Why Histologic Subtypes and Divergent Histologies Matter - Beyond the AbstractBladder CancerJune 17, 2026
-
Impact of Asymptomatic Bacteriuria on the Outcomes and Tolerability of Bacillus Calmette-Guérin Immunotherapy - Beyond the AbstractBladder CancerJune 16, 2026
-
HER2 and Urothelial Carcinoma: Current Understanding and Future Directions - Beyond the AbstractBladder CancerJune 16, 2026
-
Detection of Bladder Cancer in Patients with Microscopic Hematuria Using Oncuria-Detect: Results of a Prospective, Multicenter International Study - Beyond the AbstractBladder CancerMay 26, 2026
-
Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial Design - Beyond the AbstractBladder CancerMay 22, 2026
-
Impact of Pelvic Lymph Node Dissection on Oncological Outcomes in Patients with Clinically Staged Non-Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Systematic Review - Beyond the AbstractBladder CancerMay 22, 2026